CDIO

NASDAQ · Biotechnology

Cardio Diagnostics Holdings

Penny Stocks Biotech Stocks Healthcare Stocks

$1.89

+0.02 (+1.07%)

As of Nov 14, 2:53 AM ET ·

CDIO News1 articles

Novo Nordisk Shares Plunge 9% as ZEUS Trial Fails to Show Cardiovascular Benefit

Novo Nordisk shares fell sharply after ZEUS trial data showed no significant cardiovascular benefit, wiping out $20.5 billion in market cap and underscoring heavy reliance on GLP-1 franchise.